s u m m a r y Despite a complex relationship between mood, sleep and rhythm, the impact of circadian disruptions on bipolar disorder (BD) has not been clarified. The purpose of this systematic review was to define current evidence regarding chronotype and circadian rhythm patterns in BD patients. 42 studies were included, involving 3432 BD patients. Disruption of the biological rhythm was identified, even in drug-naïve BD patients and independently of mood status. Daily profiles of melatonin levels and cortisol indicated a delayed phase. Depression was more frequently associated with circadian alterations than euthymia. Few studies evaluated mania, demonstrating irregular rhythms. Evening type was more common in BD adults. Studies about the influence of chronotype on depressive symptoms showed conflicting results. Only one investigation observed the influences of chronotype in mania, revealing no significant association. Effects of psychoeducation and lithium on rhythm in BD patients were poorly studied, demonstrating no improvement of rhythm parameters. Studies about genetics are incipient. In conclusion, disruption in circadian rhythm and eveningness are common in BD. Prospective research evaluating the impact of circadian disruption on mood symptoms, metabolism, seasonality, the influence of age and the effects of mood stabilizers are needed.
Background
Mood disorders are multifactorial and heterogeneous conditions influenced by genetic and environmental factors. They are often associated with alterations of sleep and circadian rhythm through a complex and bidirectional relationship [1] . In bipolar disorder (BD), an association between sleep disorders, circadian rhythmicity, chronotype preference, residual mood symptoms and mood episode recurrence is suggested [2] .
Circadian rhythmicity and chronotype preference are closely related. Chronotype or morningnesseeveningness is the individual preference of the day's period for carrying out activities [3] . It reflects the 24 h or ultradian propensity for the individual either to be alert or to sleep. Three different chronotypes are identified: morning types, evening types and neither (indifferent) [4] .
Circadian rhythmicity describes variability, stability and period functional performance. Actigraphic measures can provide elements of circadian rhythmicity expressed as relative amplitude, interdaily stability and intradaily variability [5] .
Behavior alterations of the sleep-wake schedule in relation to the external environment e.g., shift work and jet lag can result in circadian rhythm and sleep-wake disorders potentially altering the alignment of the internal circadian clock with the external environment [6] . Commonly, this rhythm disruption tends to precipitate or exacerbate mood episodes [7] . Furthermore, in animal models, sleep deprivation induces manic episodes [8, 9] . It is questioned whether sleep and circadian alterations are triggers for mood symptoms [10] .
Conversely, circadian disruptions and sleep complains also can be consequence of mood disorders [11, 12] . Manic episodes are frequently characterized by reduced sleep need, while insomnia and hypersomnia occur frequently in depressive phases [13] . Interestingly, sleep loss confers a poor prognosis, increasing the risk of suicide in patients with a suicide attempt history [14] . Even in euthymia, BD patients show more sleep alterations than controls [15] . Given all this evidence, some authors theorize that BD clinical manifestations and pathogenesis can be understood as circadian rhythm alterations [16e18] .
Genetic evidence shows a strong relationship between circadian genes and susceptibility to BD [19e21] . Specific gene variants link to different kinds of mood disorders. Two polymorphisms of CLOCK (rs1801260 and rs11932595) relate with BD-II 1 ; and two of TIM (rs2291739, rs11171856), with unipolar depression [22] . Furthermore, circadian clock components can influence the response to mood stabilizers. Some circadian clock components, e.g., Per2, Cry1 and Rev-erba, probably increase individual sensibility to the therapeutic effects of lithium [23, 24] . Chronotherapeutic interventions have been successfully used in BD. Sleep deprivation combined with intensive light therapy is a good adjunct to standard treatments for depressive episodes [25] . The blue-blocking regime in mania, a virtual darkness therapy, was followed by a rapid and sustained decline in mood symptoms accompanied by a reduction in total sleep, a reduction in motor activity during sleep intervals, and an increased regularity of sleep intervals [26] . Interpersonal and social rhythm therapy potentially improves mood symptoms and prevents relapse of mood episodes [27] . A recent metanalysis involving 489 BD patients showed that light therapy reduces disease severity [28] . All these findings indicate the importance of studying the relationship between sleep, circadian rhythm and mood.
Previous evidence shows that different physiological aspects are associated with chronotypes. It is linked to both positive and negative affects, and to specific clinical conditions e.g., metabolic and sleep disorders [29e33] . Eveningness is associated with many mental disorders [34] . It is a probable independent risk factor related to severity, suicidal ideation, nonremission and poor response to treatment in depressive episodes [35e38] . Despite all this evidence, clinical repercussions of circadian rhythm alterations and chronotype preferences in BD patients need more clarification.
The objective of this study is to perform a systematic review to define current evidence about chronotype and circadian rhythm patterns in patients with bipolar disorder.
Methods

Search strategies
This review focuses on circadian rhythm and chronotype. Measures included behavior questionnaires, actigraphy, genetic and hormonal evaluation. Two researchers performed an electronic search of PubMed, Cochrane Library and ClinicalTrials.gov. Keywords used were 'chronotype' or 'circadian rhythm' or 'biological rhythm' or 'sleep' AND 'bipolar disorder' or 'mania' or 'bipolar depression'. Manual searches were also conducted, using reference lists from identified articles.
We included all articles published in the last 20 y (1995e2015) evaluating chronotype and circadian variations in BD patients. Reviews, case reports, conference abstracts, expert opinions, animal experiments and incomplete clinical trials were excluded. Articles duplicated or unavailable in the English language were removed. Research with patients with mental disorders that did not analyze bipolar disorder and other mental diseases separately was not considered. Articles that reported only sleep patterns or sleep disorders but not chronotype or circadian variations were excluded. Genetic studies were limited to those that identified relations between genes and their repercussions on biological rhythm. Interventional studies that evaluated the impact on circadian functioning were included. Articles measuring levels of hormones such as melatonin or cortisol and their daily hormonal profile were selected.
Sleep and rhythm measures
Behavior questionnaires and/or actigraphy assessed sleep and rhythm providing information about individual differences and their relationship with other biological functions. The morningness eveningness questionnaire (MEQ) is an instrument with good reliability and stability, used to describe chronotype or phase preference [39] . The circadian type questionnaire investigates the amplitude and stability of circadian rhythm [40, 41] . The composite scale of morningness (CSM) consists of 13 items from two different scales: MEQ and diurnal type scale. It assesses individual differences in the time of day that a person prefers to carry out various activities, and classifies people as morning-type or evening-type [42] . The CSM demonstrated good test-retest reliability and adequate external validity [43] . The social rhythm metric (SRM) is a self-report instrument designed to quantify social rhythm regularity. It helps to structure the day cognitively and to plan possible changes routines. The Munich chronotype questionnaire (MCTQ), a recent instrument used to determine the circadian type, is a good indicator of melatonin onset; the MCTQ is calculated by the midpoint of sleep between onset and offset on days off from work [42] . The biological rhythm interview of assessment in neuropsychiatry (BRIAN) consists of 18 items evaluating five domains: sleep, activity, sociality, eating habits and rhythm and it refers to the last 14 d [44] .
Circadian rhythm analysis can be yielded by actigraphy. Several components of circadian rhythm i.e., as relative amplitude, interdaily stability and intradaily variability are provided. It is a good instrument for estimating sleep length and fragmentation in bipolar disorder, revealing a good correlation with polysomnography [45] . Measures such as the Least5 (L5) and Most10 (M10) indicate the regularity of sleep, activity or inactivity. The L5 provides the average activity level for the sequence of the least five active hours indicating how restful (inactive) and regular the sleep periods are. The M10 average provides the average activity level for the sequence of the highest (most) 10 active hours. The onset of L5 (restful hours) and M10 (active hours) gives an indication of the phase preference or chronotype. Among BD patients in euthymia, comparisons between objective and subjective sleep and circadian markers suggest that CSM has a good association with M10 onset and L5 onset measured in actigraphy [5, 40] .
Hormonal levels such as melatonin or cortisol, determined throughout the day, can express endogenous circadian rhythm. However, isolated measures have lower reliability as a tool to indicate circadian rhythm [46] . In this review, these cases were not included.
Data analysis
All articles were displayed on a table in chronological sequence with the following data: names of authors, publication year, study design, participants, mood status, sleep and rhythm measures and main results. The results were organized, considering the following topics: 1) disruption of biological rhythm e 19 studies (45.2%); 2) chronotype e 15 studies (35.7%); 3) circadian rhythm and biomarkers e six studies (14.3%); 4) genetics e six studies (14.3%).
Results
Study selection
The initial electronic database search from 1995 to 2015 resulted in 1654 hits. Additionally, four records were found in the reference list of identified studies. Initially, 1658 articles were included. After careful examination, 1514 were excluded: 509 were published before 1995; 479 focused on other conditions; 236 were reviews, conference abstracts, and expert's opinions; 143 were duplicate; 51 animal experiments; 42 case reports; 21 incomplete studies, and 31 did not analyze bipolar disorder and other mental diseases separately; and two were unavailable in English language. Thus, 144 articles were selected about sleep and rhythm in bipolar disorder.
Thereafter, 102 articles were removed because referred to other topics: 65 concerned only sleep parameters; 12 only people at high risk for bipolar disorder (not bipolar patients); two compared objective and subjective sleep measures; and 23 focused on a population with multiple psychiatric disorders. 42 studies were finally selected (Fig. 1) .
Study description
Overall, 3432 BD patients were finally included in this review. Table 1 shows data in the following order: author and year, study design, participants (number), mood status, other characteristics (gender, age, etc.), main outcomes (sleep, rhythm, etc.) and summary results. Number of patients per study varied from 8 to 260. Studies were mostly cross-sectional and case control.
Two intervention studies were found. One randomized clinical trial (45 patients) evidenced no significant impact of psychoeducation on biological rhythms in BD [47] . Another study (29 patients) registered melatonin levels before and after exposure to light. Euthymic BD patients showed lower melatonin levels on the light night, at baseline and following light exposure and a later peak time for melatonin on the dark night [48] .
Two prospective cohorts were identified. 
Disruption of biological rhythm
19 studies (45.2%) focused on regulation of biological rhythm in BD patients and its relationships with clinical variables. All five studies (576 patients) that used subjective measures of rhythm indicated a disruption of the biological rhythm in BD patients in comparison to controls [50e55]. This was also evidenced even in drug-naïve BD patients [39] . It is suggested that disruption of biological rhythm in BD occurs independently of current mood state (p < 0.001). Differently, the biological rhythm disruption is dependent on current mood symptoms in subjects with major depressive disorder (MDD) [52] .
Four studies using actigraphy (105 patients) confirmed a less stable and more variable circadian activity patterns in BD, even in euthymia [10,56e59] . Smaller amplitude and alterations in mean activity were demonstrated in four actigraphic studies, including pediatric samples (117 patients) [58e61].
Individuals with bipolar disorder showed longer sleep duration, greater activity in active periods of sleep and greater interday stability. showed that the association between BD and interday stability remain significant after correction for multiple testing [61] .
The link between quality of life and rhythm was poorly investigated in BD patients. Cudney et al., 2016 showed that rhythm dysregulation is associated with poor quality of life in BD, independent of sleep disturbance, sleep medication, and severity of mood symptoms. Treatment strategies targeting regulation of biological rhythms may improve quality of life in this population [55] .
Few articles evaluated the bidirectional relationship between mood status and social rhythm activity. Only one prospective cohort (involving 206 patients) investigated the impact of biological rhythm on mood status. Importantly, social rhythm regularity significantly predicted the onset of major depressive, hypomanic and manic episodes [50] .
Four studies (136 patients) focused on mania; all of them were caseecontrol. Minassian et al., 2010 (28 patients) demonstrated that manic BD exhibited higher levels of motor activity when exploring novel environments [63] . Krane-Gartiser et al., 2014 (30 patients) reported lower motor activity in mania and depression compared to controls in the morning (p < 0.001), but not in the evening [64] . Mania and mixed status were associated with acrophase advance (p < 0.001) and lower daily activity (p < 0.05) than controls [47] . It was suggested that greater severity of manic symptoms correlated with less robust rhythms of locomotor activity [57] .
Circadian disturbances were more frequent in depression phase in comparison to euthymia and controls (four studies; 260 patients) Grierson [53, 54, 64, 65] . Even in residual depressive symptoms, this relationship was observed (p < 0.001) (66) . In opposition, only one study (42 patients) found no relationship between the degree of depression and circadian quotient (p ¼ 0.96) (57) . Depression was associated with lower mean activity level, higher variability, delay of circadian rhythm in evening and morning activities and poor functioning [53, 54, 64, 65] . Severity of mood symptoms correlated to less robust rhythms in BD, but not MDD [10] . Only one study evaluated the repercussions of psychoeducation on circadian rhythm on BD. 45 patients were divided into two groups: one group received a short-term psychoeducation model and medication (combined intervention), and the other received only medication (standard intervention). The model was summarized in a protocol of six individual sessions of one hour each about BD, mood status and treatment. Both groups showed remission of depressive symptoms (p ¼ 0.04), but none showed a statistically significant reduction of manic symptoms. No influence of psychoeducation on biological rhythm was observed; however, only the standard intervention group showed improvement in the following BRIAN domains: sleep (p ¼ 0.01), activity (p < 0.001), social rhythm (p ¼ 0.002) and total score (p ¼ 0.001) [48] .
Only one study analyzed the impact of mood stabilizers on rhythm in BD. In lithium-treated patients (n ¼ 39), activity levels in the evening were higher and there was a trend toward a later morning awakening during depressive episodes [66] . Other drugs were not investigated, and further studies are necessary.
A single study (18 patients) used a combined heart rate and movement registration as an indicator of rhythm alterations. It concluded that fitness, acceleration and activity energy expenditure were lower in unipolar patients, but not in the BD group (in depression or euthymia) [67] .
Circadian alterations in 14 euthymic BD patients were related to structural abnormalities in the brain, mainly concerning the dorsolateral prefrontal cortex (DLPFC) and supramarginal gyri. In the right DLPFC, positive associations were found between the mean abnormal blood oxygen-dependent level (BOLD) and amplitude of circadian rhythm while an opposite effect was found in the left side [58] .
Chronotype 15 studies (35.7%) evaluated chronotype in BD patients. Bipolar disorder was often associated with eveningness. Six studies involving 850 patients showed that evening type was more common in BD as compared to controls [41,68e72] . Eveningness was maintained for a long time and therefore, it was considered a trait marker [49] . In opposition to these findings, one study (119 patients) did not evidence difference between euthymic BD and controls [73] . Chung et al., 2012 compared the chronotypes of BD and MDD patients and no difference in circadian preference was found [74] .
Considering the BD types, rhythm comparisons between BD-I and BD-II were scarce and showed unclear results. Baek et al., 2014 (200 patients) revealed that BD-II had higher eveningness scores than BD-I during euthymia [69] ; in contrast, Chung et al., 2012 (106 patients) did not evidence differences; however, mood status was not specified [74] .
Studies about rapid cycling, a particular type of BD, were few (two studies involving 84 patients). Rapid cycling BD often had less rhythmic daily routines (p ¼ 0.01) and completed fewer activities (p ¼ 0.01) than controls [53] . Compared to non-rapid cycling BD, they were more likely to have evening preference (p < 0.02) [75] .
Only one study described the chronotype in 30 BD children. No differences between children with BD and controls were found.
However, BD adolescents (ages 13 y and older) endorsed greater eveningness compared to controls, similar to adults with BD [72] .
Few studies (n ¼ 306) showed an interface between chronotype, depressive symptoms and seasonality. In general, BD-I and BD-II had a higher global seasonality score e GSS (p < 0.028) and more seasonal affective disorders e SAD (p < 0.001) [69] . There was also a preference for evening (p < 0.01) [67, 74] . Higher fluctuations throughout seasons were also associated with a family history for mood disorders (p ¼ 0.035) [77] .
Although very important, the relationship between chronotype and metabolism was rarely studied. Soreca et al., 2009 (n ¼ 29) reported that eveningness was associated with higher percentage of body fat (p ¼ 0.004) in euthymia, measured by a dual x-ray absorptiometry. The CSM score was associated with an increase of 19% of the variance in percentage of body fat, independently of age, sex, 12-wk depression, mania score, and sleep quality [78] .
Few studies reported the relationship between chronotype, functionality and sleep in euthymia. Evening type was related to a poor sleep quality (p ¼ 0.01) in one study (67 patients) [77] and to poor functionality in BD (p < 0.001) in another (107 patients) [65] .
Studies about the influence of chronotype on depressive symptoms showed conflicting results. Wood et al., 2009 (190 patients) reported that high depression scores are more likely to be associated with evening type [70] . On the other hand, Gonzalez et al., 2014 (42 patients) found no relationship between the degree of depression and circadian quotient [57] . Furthermore, Rosa et al., 2013 (107 patients) reported a correlation between biological rhythms with residual depressive symptoms (p < 0.001) [65] , while Giglio et al., 2010 (81 patients) indicated no association between subthreshold depressive symptoms and chronotype in BD [71] . To this date, only one investigation (81 patients) observed the influences of chronotype in mania, revealing that subthreshold manic symptoms were unrelated to chronotype [71] .
Circadian rhythm and biomarkers
Six studies (14.3%) evaluated biomarker changes throughout a day. Three of them (129 patients) measured the daily profiles of melatonin [50,79,80]; and two (121 patients) evaluated cortisol levels [81, 82] . Another one (52 patients) analyzed lipid peroxidation, measuring malondialdehyde (MDA) levels and the activity of total and extracellular superoxide dismutase (SOD), catalase (CAT) and glutathione S-transferase (GST) [51] .
Evidence indicates that daily levels of melatonin may assume a different pattern during mania as compared to controls and to patients with depression. Novakova et al., 2015 (60 patients) demonstrated that the melatonin levels in mania at 15:00 and 19:00 h were significantly higher than in controls and depression, corresponding to nearly 50% of the maximal nocturnal levels. Moreover, at 07:00 h, they were significantly lower. Otherwise, no differences were found between melatonin profiles of controls and depressive patients [80] . Melatonin secretion abnormalities were confirmed in a subgroup of euthymic BD patients: lower melatonin levels and a later peak time for melatonin was confirmed [48] . Another study (18 patients) compared melatonin levels in depressive BD and MDD groups, concluding that BD patients showed later dim light melatonin onset e DLMO (melatonin concentration above 3.000 pg/mL) and smaller melatonin area under the curve e AUC (corresponding mean melatonin concentrations over the day) than the MDD patients. In this study, DLMO occurred after habitual sleep onset in one third of patients with mood disorders. Thereby, these findings indicate that BD patients show delayed and lower evening melatonin secretion [79] .
The cortisol daily profile of BD patients probably presents a specific pattern. Girshkin et al., 2016 (56 patients) showed that BD M.C.A. Melo et al. / Sleep Medicine Reviews xxx (2016) 1e13 8 had higher levels of cortisol at waking and increased cortisol levels in response to a stressful exam (magnetic resonance imaging e MRI) than schizophrenia (but not controls). Interestingly, cortisol patterns were associated with different variables in BD and schizophrenia: lower waking cortisol indices related to longer illness duration in BD, and to greater symptom severity in schizophrenia [82] . Associations between cortisol levels and cognitive functioning or depressive symptoms were not evidenced [81] .
Cudney et al., 2014 (52 patients) suggested that circadian disturbance was independently associated with increased lipid peroxidation in BD (p < 0.05), but not in controls. A reduced extracellular SOD (p < 0.05) in BD was observed, but no differences in total SOD, CAT or GST activity was found [51] . No study correlated inflammatory cytokines and rhythm disorders in BD.
Genetics
Six studies (14.3%) evaluated the impact of genetic alterations on circadian rhythm: two (299 patients) analyzed the CLOCK gene [64, 81] ; one (25 patients), acetylserotonin O-methyltransferase (ASMT) gene [60] ; the fourth (8 patients) investigated polymorphisms in 15 genes: ARNTL, BHLHE40, BHLHE41, CLOCK, CRY1, CRY2, CSNK1D, CSNK1E, DBP, NFIL3, NPAS2, NR1D1, PER1, PER2, and PER3 [82] . Two studies evaluated polymorphisms in other circadian genes [19, 85] .
Lee et al., 2010 (260 patients) studied a single nucleotide polymorphism (SNP) in the 3 0 -flanking region of CLOCK (3111T/C; rs1801260), whose 3111T/C variant showed significant allelic and genotypic associations with bipolar disorder (p ¼ 0.012 and p ¼ 0.033). Furthermore, C allele carriers (C/C and C/T genotypes) were more associated with eveningness (p ¼ 0.041) [83] . Similarly, Benedetti et al., 2007 (39 patients) found that C variant was associated with higher evening activity (p ¼ 0.007), a delayed sleep onset (mean 79 min later), and a reduced amount of sleep during the night (mean 75 min less) [66] .
Geoffroy et al., 2014 (25 patients) focused on polymorphism (rs4446909) of the promoter of the ASMT gene, encoding one of the two enzymes involved in melatonin biosynthesis. An association between the GG at-risk genotype was found with each of the following variables: longer sleep duration (p ¼ 0.03), greater activity during active periods of the night (p ¼ 0.015) and higher interday stability (p ¼ 0.003) [62] . Kripke et al., 2014 (8 patients) showed that delayed sleep and "eveningness" were inversely associated with loci in circadian genes NFIL3 (rs2482705) and RORC (rs3828057). Some BHLHE40 alleles were associated with non-24-h sleep-wake cycles, and less robustly, with delayed sleep and bipolar disorder (e.g., rs34883305, rs34870629, rs74439275, and rs3750275) [84] . Kripke et al., 2009 (130 patients) revealed that bipolar disorder was associated with genes NR1D1 (rs2314339), suggesting that perturbations of the circadian gene network at several levels may influence mood disorders [85] . Polymorphisms of PER3 and CSNK1E were associated with greater eveningness in BD patients.
Etain et al., 2014 (239 patients) demonstrated that rs774045 in TIMELESS was associated with eveningness whereas rs782931 in RORA was associated with rigid circadian type indicating these variants in the TIMELESS and RORA genes may confer susceptibility to BD and impact on circadian phenotypes in carriers [19] .
Discussion
The vast majority of studies showed a disruption of circadian rhythm and an evening preference in BD patients, independently of mood status. Interestingly, MDD contrasts with this evidence, demonstrating that rhythm disruption is dependent on current mood symptoms [52] . Some studies showed that circadian alterations in BD were more frequent in individuals with depression than in euthymic patients [53, 54, 64, 65] . Circadian disruptions were established even in drug naïve patients [52] . Actigraphic studies confirmed the disruption of the circadian rhythm [10,56e59] . Based on all this evidence, it is licit to conclude that circadian rhythm alterations are present in BD; however, the role of mood status is unclear.
Few studies involved patients in manic state. Mania and mixed status were associated with acrophase advance and lower daily activity [61] . In addition, greater severity of manic symptoms correlated with less robust rhythms [56] . The paucity of evidence related to mania possibly relates to the obvious clinical limitations of studying these patients. This aspect needs more clarification.
Circadian disturbances may have a role in the pathogenesis of mood disorders. showed that young patients with mood disorders, especially those with BD, are likely to have a delayed sleep phase [86] . Actigraphic studies in BD patients show sleep abnormalities during depressive, manic, and interepisode periods [87] . In light of these evidences, when analyzing sleep disturbances, attention to age, circadian changes and levels of residual depressive symptoms must be taken into consideration [88] .
Similarly, patients with other psychiatric disorders, such as major depression, anxiety disorders and schizophrenia often show circadian dysregulation of hormonal and behavioral processes contributing to major functional impairment [89, 90] . Rhythm disruption has been associated with disease severity in some psychiatric disorders, e.g., increased suicidal ideation in patients with MDD [58] .
Evidence on circadian alterations in BD is mostly based on crosssectional evaluations; therefore, a causeeeffect relationship cannot be established. Interestingly, one prospective study showed that less social rhythm regularity predicted a shorter time between affective episodes [50] . These preliminary results are promising and it is fair to hypothesize that interference in the circadian rhythm could reduce affective symptoms.
One study tested the effects of psychoeducation in BD patients and suggested no significant influence on circadian changes [48] . Psychoeducation is not a conventional and recommended measure to modify circadian patterns. A change of rhythm can be achieved using measures such as light exposure, physical exercise and sleep hygiene [20, 91] . Randomized trials focusing on circadian changes may clarify whether a long-term interference will affect the expression of mood symptoms.
One important and isolated study demonstrated effects of lithium therapy on circadian patterns in BD patients, characterized by higher evening activity and later morning awakening [66] . In vitro studies of fibroblasts from BD patients show weaker amplification of circadian rhythm by lithium and this possibly relates to calcium signaling. Possibly, a low amplitude circadian rhythm associated with lithium therapy could influence therapeutic results [23, 92] . Genetic studies further confirm a relationship between circadian rhythm and lithium showing that the expression of circadian clock components, including Per2, Cry1 and Rev-erba, is affected by lithium treatment [24] . A systematic review reveals that chronic lithium treatment stabilizes activity rhythms: it delays circadian rhythms and peak of body temperature, and reduces amplitude and duration of activity rhythms [18] . Given all this evidence, clinical studies evaluating the impact of lithium and other mood stabilizers on circadian rhythm and the influence on therapeutic results are warranted.
A single study shows that circadian alterations in BD are linked to structural abnormalities in the brain mainly concerning the dorsolateral prefrontal cortex (DLPFC) and supramarginal gyri. Prefrontal dysregulation is associated with trait impulsivity and impairment in working memory [93, 94] . Reduced white matter integrity is also observed in bipolar patients, suggesting cognitive repercussions [95, 96] . Studies investigating alterations of functional neuroimaging in BD related to rhythm disruption were not found. These preliminary findings deserve confirmation. Interestingly, one single study showed that children with BD did not have eveningness preference; in contrast, eveningness was already present in adolescents [72] . Recently, objective measures of sleep, circadian rhythmicity, and hyperactivity were abnormal in children with BD [59] . Reduced relative circadian amplitude was a distinctive feature. Generally, adolescents tend to sleep less, go to bed and get up later, and experience greater daytime sleepiness and weekend compensation for sleep shortage on weekdays, compared to younger children [97] . In fact, studies investigating sleep-wake patterns in preadolescents and in children are scarce [98, 99] . Future samples should include both youth and adults with BD.
Comparisons between chronotype preference and BD types were scarce. One study showed that BD-II was more associated with eveningness. Ab e et al., 2015 indicated that both BD subtypes showed cortical abnormalities, such as lower volume, thickness and surface area in frontal brain regions. However, BD-I had abnormally low cortical volume and thickness in temporal and medial prefrontal regions [100] . More studies on neuroanatomy and pathophysiology could possibly explain the differences in clinical manifestation and patterns of circadian rhythm between BD-I and II.
In BD, few studies showed an interface between chronotype, depressive symptoms and seasonality. Preliminary evidence showed that BD-I and BD-II had a higher GSS and more seasonal affective disorders [69] . Higher fluctuations throughout seasons were also associated with a family history for mood disorders in bipolar patients [76] . The latter evidence helps to consolidate the common biological ground between mood, circadian rhythm and seasonality in BD. Recently, two rare variants in the circadian clock gene PERIOD3 (PER3-P415A/ H417R) in humans with familial advanced sleep phase and depression and seasonality were identified indicating a possible role for PER3 in mood regulation [101] . Seasonal affective disorders are frequently reported during winter in regions with reduced levels of light; however, the effects of seasonal variation on circadian rhythm, chronotype expression, sleep and mood symptoms are unclear [102] .
Studies about influence of chronotype on depressive symptoms showed conflicting results. To this date, only one investigation observed the impact of circadian preference in mania, revealing that subthreshold manic symptoms were unrelated to chronotype [71] . In population based studies, eveningness has been associated with depressive symptoms [103, 104] . In MDD, evening preference was related to poor therapeutic response [37, 38] . Jankowski et al., 2016 suggested that morning affect may be responsible for the link between circadian preference and depressive symptoms. People with eveningness without low morning affect had less depressed/ somatic symptoms [105] . To the best of our knowledge, this issue has not been investigated in BD patients.
Despite the clinical relevance due to its frequency, morbidity and mortality, metabolic abnormalities, eating patterns and circadian variations were rarely evaluated in BD patients. Previously, eveningness was associated with higher percentage of body fat and depressive symptoms [78] . Changes in the clock system alter the neuroendocrine pathways within the hypothalamus. These structures are involved in feeding and energetics [106] . Chronically, rhythm desynchronization can enhance inflammatory mediators and may increase the risk of cardiovascular and metabolic diseases [107] . Previously, a link between a high BMI and several sleep disturbances in BD, including lower sleep efficiency has been established [108] . Given the high prevalence of these diseases, it is important to identify the impact of sleep and circadian disorders in the development and course of metabolic disease.
Considering biomarkers, preliminary evidence showed a dysregulation of daily levels of melatonin and cortisol. In relation to oxidative stress, circadian rhythm disturbance was associated with increased lipid peroxidation in BD [51] . Many authors consider BD an inflammatory condition [109e111]. To date, no study focused on the relationship between inflammatory cytokines and biological rhythms. Of note, circadian dysregulation entails changes in immune system and increase vulnerability to infections. Immune parameters also show daily variations, demonstrating a circadian pattern [112] .
Currently, studies involving genetics are incipient. Many circadian genes have been associated with BD [113e115]. However, studies assessing how these genes influences circadian rhythm in BD are less frequent. It is suggested that chronotherapies, including sleep deprivation and sleep phase advance, modify clock gene machinery and it can represent a pathophysiological explanation to improvement of mood symptoms [116] .
Several limitations need to be acknowledged. Different study designs, various kinds of circadian rhythm outcomes, and heterogeneous mood status prevented us from performing a metaanalysis. Most studies were cross-sectional, hampering a causeeeffect relationship. The majority of them were based only on subjective parameters, and studies with actighaphy or biomarkers were less frequent. However, this review included 3432 patients with BD evaluating aspects related to chronotype, circadian disruption, disease severity, biomarkers, genetic influences and therapeutic aspects. The evidence clarifies some issues and gives avenues to new investigations.
In conclusion, circadian rhythm disruption and eveningness are common in BD. However, the impact on mood status is still unclear. More prospective research is needed. Future studies should focus on therapy, outcomes, metabolic alterations, rapid cycling, biomarkers variability, children's evaluation, and brain structural abnormalities. Longitudinal data that assess when/how circadian preference/rhythms change, and how these changes relate to age of diagnosis and symptom severity could expand the knowledge about the subject.
Practice points 1) Disruption of circadian rhythm was identified, even in drug-naïve BD patients. Actigraphy confirmed this finding, independently of mood status. Studies showing alterations in daily profiles of melatonin levels and cortisol reinforced circadian dysregulations in BD. 2) Evening type was more common in BD adults. It was suggested that children did not show eveningness; however, this circadian preference was already found in adolescents. The influence of chronotype on mood symptoms remains unclear. 3) Genetic studies involving circadian rhythm are incipient.
Analysis of the circadian genes suggested that eveningness is more associated with C allele carriers in CLOCK genes and inversely related to loci in circadian genes NFIL3 (rs2482705) and RORC (rs3828057).
Research agenda
Areas for future research may include:
1) Repercussions of circadian disruption on mood symptoms. 2) Influence of morning affect on chronotype and mood symptoms. 3) Relationships between metabolic abnormalities, eating patterns and circadian variations. 4) Profile of the circadian rhythm in children, adolescents and adults with BD. 5) Relationship between rapid cycling, chronotype and biological rhythm. 6) Effects of mood stabilizers on circadian patterns. 7) Associations between neuroanatomy, inflammatory mediators and biological rhythm.
